Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2014 07:00 ET | Source: Trillium Therapeutics Inc.

Trillium Therapeutics Provides Corporate Update and Announces Reverse Stock Split for NASDAQ Listing

TORONTO, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ("Trillium") (TSX:TR) (OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, today...
August 07, 2014 07:00 ET | Source: Trillium Therapeutics Inc.

Trillium Therapeutics Expands CD47 Program Into Solid Tumors Through a Broad Academic Collaboration

TORONTO, ONTARIO--(Marketwired - Aug. 7, 2014) - Trillium Therapeutics Inc. ("Trillium") (TSX:TR)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the...
June 13, 2014 10:00 ET | Source: Trillium Therapeutics Inc.

Trillium Therapeutics Receives Prestigious National Award

TORONTO, ONTARIO--(Marketwired - June 13, 2014) - Trillium Therapeutics Inc. ("TTI") (TSX:TR)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the...
June 02, 2014 09:00 ET | Source: Stem Cell Therapeutics Corp.;Trillium Therapeutics Inc.

Stem Cell Therapeutics Changes Its Name to Trillium Therapeutics Inc.

TORONTO, ONTARIO--(Marketwired - June 2, 2014) - Stem Cell Therapeutics Corp. ("SCT") (TSX:SSS)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment...
May 28, 2014 08:45 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Results of Annual Shareholders Meeting

TORONTO, ONTARIO--(Marketwired - May 28, 2014) - Stem Cell Therapeutics Corp. ("SCT") (TSX:SSS)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment...
April 21, 2014 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Graduates to the Toronto Stock Exchange

TORONTO, ONTARIO--(Marketwired - April 21, 2014) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related...
April 03, 2014 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics to Provide Update on CD47 Program at the 2014 American Association for Cancer Research Annual Meeting

TORONTO, ONTARIO--(Marketwired - April 3, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
March 10, 2014 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Strengthens its Board of Directors

TORONTO, CANADA--(Marketwired - March 10, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
January 30, 2014 07:37 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman

TORONTO, ONTARIO--(Marketwired - Jan. 30, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
January 27, 2014 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Resignation of Director

TORONTO, ONTARIO--(Marketwired - Jan. 27, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...